ReviewFrontiers in oncology2022

Osimertinib-Centered Therapy Against Uncommon Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer- A Mini Review.

Chengyang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.